Tadalafil
Product Images NDC 50436-7010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50436-7010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504367001)

Label Image (Lbl504367001)
NDC 50436-7001-1 is a package of 30 tablets of Tadalafil at a strength of 2.5 mg per tablet. The tablets contain Tadalafil as an active ingredient. It is warned not to split the tablet and the full dose should be taken. The container used for dispensing should be tight and kept out of the reach of children. The tablets should be stored at a controlled room temperature of 25°C (77°F). The manufacturer is identified as Eli Lily and Company located in Indianapolis, USA. The product has dosage information on the package insert. The MFG NDC is 66993-700-30 and the lot number is X00000¢ with a serial number of 000000011. The product is authorized for prescription-only use and the NOC is 50436-70011. The text in the also includes some additional information that is not readable.*
FDA Label Image

Label Image (Lbl504367010)

Label Image (Lbl504367010)
This appears to be a label for a medication with the active ingredient Tadalafil in 5mg tablets form. The product information such as the intended use, dosage instructions, warnings, and side effects are not provided. The label also includes a National Drug Code (NDC) which is a unique identifier for drugs in the United States. However, the bottom portion of the label appears to be cut off and is unreadable.*
FDA Label Image

Structural Formula (Tadalafil Uspi 01)

FDA Label Image

Figure 1 (Tadalafil Uspi 02)

FDA Label Image

Figure 2 (Tadalafil Uspi 03)

FDA Label Image

Figure 3 (Tadalafil Uspi 04)

Figure 3 (Tadalafil Uspi 04)
This text describes a table with four rows representing different drug regimens: 20mg tadalafil and 8mg dommmoen; placebo and B mg doxazosin; 20mg tadalafil and 8mg doxazosin, 8 mg doxazosin and placebo. The columns of the table represent systolic blood pressure measurements at different times after administration of the drugs. However, there seems to be some inconsistencies and mistakes in the text, such as the incomplete drug name "dommmoen" and the strange time format used for the administration of the drugs. Overall, the text is not very useful due to these errors.*
FDA Label Image

Figure 4 (Tadalafil Uspi 05)

FDA Label Image

Figure 5 (Tadalafil Uspi 06)

FDA Label Image

Figure 6 (Tadalafil Uspi 07)

FDA Label Image

Figure 7 (Tadalafil Uspi 08)

FDA Label Image

Figure 8 (Tadalafil Uspi 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.